TickerFacts.

Foxo Technologies Inc. (FOXO): Net Income

Annual figures by period end, from SEC filings.

-$12.43M
Year ended 2025-12-31
-$4.60M
Trailing 12 months to 2026-06-30
2021-12-31: -$38.49M2022-12-31: -$95.25M2023-12-31: -$26.45M2024-12-31: -$12.41M2025-12-31: -$12.43M-$12.43M
2021-12-31 Net Income (USD) 2025-12-31
Period endedNet IncomeChange YoYSource filing
2025-12-31-$12.43Mn/m2026-04-15, From 2025-01-01
2024-12-31-$12.41Mn/m2026-04-15, From 2024-01-01
2023-12-31-$26.45Mn/m2025-04-15, From 2023-01-01
2022-12-31-$95.25Mn/m2024-06-06, From 2022-01-01
2021-12-31-$38.49Mn/a2023-03-31, From 2021-01-01

Net Income at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedNet IncomeChange YoY
Foxo Technologies Inc. (FOXO)2025-12-31-$12.43Mn/m
OmniAb, Inc. (OABI)2025-12-31-$64.78Mn/m
MaxCyte, Inc. (MXCT)2025-12-31-$44.63Mn/m
bioAffinity Technologies, Inc. (BIAF)2025-12-31-$14.91Mn/m
Absci Corp (ABSI)2025-12-31-$115.18Mn/m
NRC Health (NRC)2025-12-31$11.60M-53.2%
iSpecimen Inc. (ISPC)2025-12-31-$10.49Mn/m
OneMedNet Corp (ONMD)2025-12-31-$2.80Mn/m
Cannabis Bioscience International Holdings, Inc. (CBIH)2025-05-31-$548.8Kn/m

Compare FOXO, OABI, MXCT, BIAF side by side · Screen every company in Services-Commercial Physical & Biological Research ↗